Actively Recruiting
Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
Led by Modern Biosciences Ltd · Updated on 2024-08-09
48
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A DDI study consisting of 4 parts conducted as an open label, fixed sequence study in healthy adult subjects.
CONDITIONS
Official Title
Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy adults aged 18 to 55 years
- Male or female of non-childbearing potential
You will not qualify if you...
- History or presence of any clinically significant medical or psychiatric condition
- History of any illness that could affect study results or increase risk to participant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Celerion
Belfast, United Kingdom
Actively Recruiting
Research Team
S
Study Team
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here